July 17, 2014 Santhera Pharmaceuticals announced today the initiation of a clinical program with omigapil, a drug candidate in-licensed from Novartis and repositioned for therapeutic …
July 17, 2014 Santhera Pharmaceuticals announced today the initiation of a clinical program with omigapil, a drug candidate in-licensed from Novartis and repositioned for therapeutic …